Abstract
Prior studies identified a segment of the CD2 cytoplasmic domain between amino acid (aa) residues 253 and 287 as important in T lymphocyte signal transduction. This region contains two repeats of the sequence motif PPPGHR, thought to form a "cage" structure involved in CD2-mediated signaling. To evaluate this segment, a series of mutant human CD2 molecules were produced by oligonucleotide-directed mutagenesis and inserted into the ovalbumin-specific, I-Ad-restricted murine T-T hybridoma 3DO54.8 using the DOL retroviral system. CD2 M1 (271-272), CD2 M2 (278-279), and CD2 M4 (264-265) mutants replaced the positively charged adjacent aa histidine and arginine (HR) in the wild-type CD2 sequence with aspartic and glutamic acid (DE) at positions 271-272, 278-279, and 264-265, respectively. In addition, a truncation mutant, CD2 M3 (268), containing only 57 of the 117 cytoplasmic aa and terminating before the second PPPGHR sequence, was generated. Stimulation of transfectants CD2 FL, CD2 M1 (271-272), and CD2 M2 (278-279) with anti-T11(2) + anti-T11(3) antibodies resulted in a rise in cytosolic-free calcium [( Ca2+]i) and subsequent interleukin 2 (IL-2) secretion. In contrast, CD2 M4 (264-265) transfectants could not be activated in either assay. Thus, alteration of histidine 264 and/or arginine 265 within the first PPPGHR motif affects the process of signal transduction via CD2, whereas identical mutations in residues at 271-272 or 278-279 were individually without effect. Consistent with these data, CD2 M3 (268) transfectants were able to generate a detectable amount of IL-2 via CD2 triggering. These data support the notion that the PPPGHR motif at aa 260-265 is important for activation of T lymphocytes via the CD2 molecule.
MeSH Terms
Amino Acid Sequence
Amino Acids/immunology
Animals
Antigens, Differentiation, T-Lymphocyte/genetics,immunology
Base Sequence
CD2 Antigens
Calcium/metabolism
Cell Line
DNA
Gene Expression/genetics
Humans
Interleukin-2/biosynthesis
Lymphocyte Activation/immunology
Mice
Molecular Sequence Data
Mutation
Peptide Fragments/genetics,immunology
Receptors, Immunologic/genetics,immunology
T-Lymphocytes/immunology
Transfection
Chemicals
Amino Acids
Antigens, Differentiation, T-Lymphocyte
CD2 Antigens
Interleukin-2
Peptide Fragments
Receptors, Immunologic
DNA
Calcium
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Chang H C
Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Moingeon P
Pedersen R
Lucich J
Stebbins C
Reinherz E L
References (11)
11 references, click to expand
-
Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.
Nature. 1987 Mar 19-25;326(6110):298-301
PMID: 3102975
-
The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3.
Nature. 1987 Mar 26-Apr 1;326(6111):400-3
PMID: 2951597
-
Molecular cloning and expression of T11 cDNAs reveal a receptor-like structure on human T lymphocytes.
Proc Natl Acad Sci U S A. 1987 May;84(9):2941-5
PMID: 2883656
-
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5698-702
PMID: 3165197
-
A role in transmembrane signaling for the cytoplasmic domain of the CD2 T lymphocyte surface antigen.
Cell. 1988 Sep 23;54(7):979-84
PMID: 2901293
-
The T11 glycoprotein is functionally linked to a calcium channel in precursor and mature T-lineage cells.
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2614-8
PMID: 2422657
-
Expression of a functional CD3-Ti antigen/MHC receptor in the absence of surface CD2. Analysis with clonal Jurkat cell mutants.
J Exp Med. 1988 Dec 1;168(6):2077-90
PMID: 3264323
-
The structural biology of CD2.
Immunol Rev. 1989 Oct;111:111-44
PMID: 2576417
-
An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.
Cell. 1984 Apr;36(4):897-906
PMID: 6231105
-
T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.
J Immunol. 1985 Sep;135(3):1624-31
PMID: 2410496
-
Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
J Exp Med. 1988 Sep 1;168(3):1145-56
PMID: 2459290